Amedisys Stock Price Prediction
| AMED Stock | USD 85.54 0.01 0.01% |
Oversold Vs Overbought
35
Oversold | Overbought |
Quarterly Earnings Growth (0.35) | EPS Estimate Next Quarter 1.15 | EPS Estimate Current Year 4.4025 | EPS Estimate Next Year 4.9582 | Wall Street Target Price 96.3333 |
Using Amedisys hype-based prediction, you can estimate the value of Amedisys from the perspective of Amedisys response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Amedisys to buy its stock at a price that has no basis in reality. In that case, they are not buying Amedisys because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Amedisys after-hype prediction price | USD 85.38 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Amedisys |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Amedisys' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Amedisys After-Hype Price Prediction Density Analysis
As far as predicting the price of Amedisys at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Amedisys or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Amedisys, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Amedisys Estimiated After-Hype Price Volatility
In the context of predicting Amedisys' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Amedisys' historical news coverage. Amedisys' after-hype downside and upside margins for the prediction period are 84.35 and 86.41, respectively. We have considered Amedisys' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Amedisys is very steady at this time. Analysis and calculation of next after-hype price of Amedisys is based on 3 months time horizon.
Amedisys Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Amedisys is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Amedisys backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Amedisys, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.19 | 1.03 | 0.15 | 0.03 | 9 Events / Month | 9 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
85.54 | 85.38 | 0.18 |
|
Amedisys Hype Timeline
Amedisys is presently traded for 85.54. The entity has historical hype elasticity of -0.15, and average elasticity to hype of competition of -0.03. Amedisys is forecasted to decline in value after the next headline, with the price expected to drop to 85.38. The average volatility of media hype impact on the company price is about 127.16%. The price decrease on the next news is expected to be -0.18%, whereas the daily expected return is presently at -0.19%. The volatility of related hype on Amedisys is about 574.88%, with the expected price after the next announcement by competition of 85.51. About 90.0% of the company shares are held by institutions such as insurance companies. The book value of Amedisys was presently reported as 35.05. The company has Price/Earnings To Growth (PEG) ratio of 1.14. Amedisys had not issued any dividends in recent years. The entity had 4:3 split on the 5th of December 2006. Given the investment horizon of 90 days the next forecasted press release will be in about 9 days. Check out Amedisys Basic Forecasting Models to cross-verify your projections.Amedisys Related Hype Analysis
Having access to credible news sources related to Amedisys' direct competition is more important than ever and may enhance your ability to predict Amedisys' future price movements. Getting to know how Amedisys' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Amedisys may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ACHC | Acadia Healthcare | (0.19) | 7 per month | 0.00 | (0.27) | 3.85 | (5.78) | 21.88 | |
| ADUS | Addus HomeCare | (2.43) | 12 per month | 0.00 | (0.1) | 2.50 | (2.69) | 8.16 | |
| EHC | Encompass Health Corp | 0.92 | 12 per month | 0.80 | 0.03 | 1.74 | (1.48) | 9.75 | |
| ENSG | The Ensign Group | (3.12) | 10 per month | 0.00 | (0.14) | 2.32 | (2.09) | 10.08 | |
| OPCH | Option Care Health | (0.45) | 9 per month | 0.00 | (0.15) | 2.91 | (3.67) | 26.20 | |
| UHS | Universal Health Services | 0.72 | 10 per month | 0.00 | (0.17) | 2.40 | (4.06) | 14.88 | |
| SGRY | Surgery Partners | 1.50 | 8 per month | 0.00 | (0.19) | 3.72 | (4.88) | 17.97 | |
| EHAB | Enhabit | 0.05 | 9 per month | 2.08 | 0.01 | 5.22 | (4.01) | 11.79 | |
| PNTG | Pennant Group | (0.81) | 9 per month | 0.00 | (0.08) | 4.12 | (3.74) | 12.42 | |
| INNV | InnovAge Holding Corp | 0.16 | 6 per month | 0.00 | (0.18) | 4.23 | (4.81) | 11.60 | |
| NHC | National HealthCare | 1.23 | 10 per month | 1.56 | (0.05) | 3.12 | (2.32) | 11.56 | |
| HCSG | Healthcare Services Group | 0.27 | 11 per month | 2.22 | 0.1 | 2.86 | (3.52) | 11.71 |
Amedisys Additional Predictive Modules
Most predictive techniques to examine Amedisys price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Amedisys using various technical indicators. When you analyze Amedisys charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Amedisys Predictive Indicators
The successful prediction of Amedisys stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Amedisys, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Amedisys based on analysis of Amedisys hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Amedisys's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Amedisys's related companies. | 2023 | 2024 (projected) | Dividend Yield | 2.91E-4 | 2.59E-4 | Price To Sales Ratio | 1.38 | 0.86 |
Story Coverage note for Amedisys
The number of cover stories for Amedisys depends on current market conditions and Amedisys' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Amedisys is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Amedisys' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Amedisys Short Properties
Amedisys' future price predictability will typically decrease when Amedisys' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Amedisys often depends not only on the future outlook of the potential Amedisys' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Amedisys' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 32.6 M | |
| Cash And Short Term Investments | 126.5 M |
Complementary Tools for Amedisys Stock analysis
When running Amedisys' price analysis, check to measure Amedisys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amedisys is operating at the current time. Most of Amedisys' value examination focuses on studying past and present price action to predict the probability of Amedisys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amedisys' price. Additionally, you may evaluate how the addition of Amedisys to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |